CD8A and neoplasm: On day 7 post vector injection CAR T cell levels in both rapamycin groups made up about 2% of CD8 cells, which was about two‐fold higher than in the vehicle group (Figure 6E), which nicely corresponded to the more rapid tumor cell clearance in the low dose group monitored by in vivo imaging.